Residential College | false |
Status | 已發表Published |
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China | |
Luo,Erdan1; Zhang,Daiyan1; Luo,Hua1; Liu,Bowen1; Zhao,Keming2,3; Zhao,Yonghua1; Bian,Ying1; Wang,Yitao1 | |
2020-04-15 | |
Source Publication | Chinese Medicine |
ISSN | 1749-8546 |
Volume | 15Pages:34 |
Abstract | Background: A novel coronavirus was identified in December, 2019 in Wuhan, China, and traditional Chinese medicine (TCM) played an active role in combating the novel coronavirus pneumonia (NCP) caused by this fast-spreading virus COVID-19. Thus, we aimed to explore TCM characteristics of clinical efficacy to NCP, as well as to optimize Qingfei Paidu decoction (QFPDD) and the recommended formulas to NCP by National Health Commission (NHC). Methods: Chinese medical sciences theory and clinical application of TCM were analyzed. A total of 54 NCP patients were observed in a hospital from Wuhan, whose clinical characteristics and utilization of Chinese Medicines (CMs) were described. Paired t test was used to measure the change of patients' hemogram during hospitalization period, indicating the effect of CMs. Multiple linear regression analysis was applied to explore the factors affecting the length of hospital stay. Network pharmacology analysis was applied to figure out the performance of NHC-recommended formulas of five disease stages at levels of compounds, targets and pathways. Result: The average length of hospital stay was 8.96 days. Patients over 45 stayed 9.79 days in hospital in average, longer than 7.64 days of patients under 45. Comparing the hemograms between admission and discharge of hospital, the number of leukocytes, neutrophil, lymphocyte and platelet increased, while the numbers of erythrocytes, hemoglobin concentration and hematocrit decreased. According to the standard coefficients of regression, the factor affecting the length of stay for the most was CMs in category of invigorating spleen and removing dampness (ISRD), followed by administrating CMs, male, and cough. Thirty-two CMs were screened after deleting duplication from QFPDD and NHC-recommended formulas. Compound quercetin, luteolin, kaempferol, acacetin etc., were all involved in the treatment of various disease stages on the compound level both in generality and individuality. Conclusion: TCM has a systemic theoretical understanding on the pathological evolution and a positive clinical efficacy on NCP. The CMs of ISRD improved patients' recovery, suggesting the importance of regulating intestinal function and keeping microenvironmental balance in TCM treatment of NCP. The active compounds from QFPDD and NHC-recommended formulas contribute to recovery of varied disease progresses during TCM treating NCP. |
Keyword | Empirical Study Novel Coronavirus Pneumonia Traditional Chinese Medicine Treatment Efficacy Wuhan China |
DOI | 10.1186/s13020-020-00317-x |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Integrative & Complementary Medicine ; Pharmacology & Pharmacy |
WOS Subject | Integrative & Complementary Medicine ; Pharmacology & Pharmacy |
WOS ID | WOS:000528746300001 |
Publisher | BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND |
Scopus ID | 2-s2.0-85083864199 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | THE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU) Institute of Chinese Medical Sciences |
Corresponding Author | Zhao,Yonghua; Bian,Ying |
Affiliation | 1.State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macao 2.First Affiliated Hospital,Liaoning University of Traditional Chinese Medicine,Shenyang,China 3.Medical Treatment Expert Group to Support for Covid-19 Control in Jihe Hospital,Wuhan,Caidian District,Hubei province,China |
First Author Affilication | Institute of Chinese Medical Sciences |
Corresponding Author Affilication | Institute of Chinese Medical Sciences |
Recommended Citation GB/T 7714 | Luo,Erdan,Zhang,Daiyan,Luo,Hua,et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China[J]. Chinese Medicine, 2020, 15, 34. |
APA | Luo,Erdan., Zhang,Daiyan., Luo,Hua., Liu,Bowen., Zhao,Keming., Zhao,Yonghua., Bian,Ying., & Wang,Yitao (2020). Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China. Chinese Medicine, 15, 34. |
MLA | Luo,Erdan,et al."Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China".Chinese Medicine 15(2020):34. |
Files in This Item: | Download All | |||||
File Name/Size | Publications | Version | Access | License | ||
NCP1.pdf(3256KB) | 期刊论文 | 作者接受稿 | 开放获取 | CC BY-NC-SA | View Download |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment